• Carcinoma in situ of stomach
  • Mucolipidosis Type IV (MCOLN1) Mutation Analysis
  • C1 Esterase Inhibitor, Antigen
  • Hypopituitarism
  • Folic Acid (Folate), RBC
  • Chromosome Analysis, Skin Biopsy
  • Cerebrospinal Fluid Microscopic Evaluation, Cell Count and Differentiation
  • Dexamethasone Suppression Test (High Dose)
  • Creatinine, 24 Hour, Urine
  • Autoimmune thyroiditis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MYOZ2 (Calsarcin-1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MYOZ2 (Calsarcin-1) Gene Mutation Analysis
Medical Test

Methodology
Access to MYOZ2 (Calsarcin-1) Gene Mutation Analysis is restricted.